Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

The document describes how to tell different types of non-scarring hair loss apart by looking at hair and scalp tissue under a microscope.

Asia has made significant progress in tissue engineering and regenerative medicine, but wider clinical use requires more development.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

Pegvaliase is recommended for treating adults with phenylketonuria.

Changes to the Foxp3 protein affect how well regulatory T cells can control the immune system, which could help treat immune diseases and cancer.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

Hidradenitis suppurativa is caused by genetic factors, inflammation, bacteria, hormones, and lifestyle factors like obesity and smoking.

Toxic Shock Syndrome progresses quickly, often involves multiple organs, and is linked to Staphylococcus aureus toxins, with treatment options available but diagnostic challenges remaining.

CCCA is a hair loss type affecting African women, possibly caused by grooming and chemicals, with various treatments and needing more research.

Biotin treatment can significantly improve hair loss and motor functions in certain metabolic disorders.

Dermatologists need to understand African American hair-care practices to better treat their hair and scalp disorders.

Engineered exosomes show promise for improving wound healing but face challenges in clinical use.

HFMs can help study hair growth and test potential hair growth drugs.

The document concludes that early recognition and treatment of primary cicatricial alopecia is crucial to prevent permanent hair loss.

Acne keloidalis nuchae is a tough-to-treat condition that greatly affects quality of life, especially in men of African descent.

SHBG may be a useful early indicator and treatment target for PCOS.

Alopecia areata involves immune system imbalances that may lead to depression and anxiety.

Aging and chronic inflammation weaken the immune system, increasing cancer and infection risks.

TGFβ's manipulation of inflammation and immune cells affects cancer spread, suggesting new treatment strategies and biomarkers.

Cannabinoids may help treat chronic and chemotherapy-induced neuropathic pain, but more research is needed to confirm their effectiveness and safety.

RANK is a key target in breast cancer treatment due to its role in tumor growth and bone metastasis.

Regenerative pharmacology, which combines drugs with regenerative medicine, shows promise for repairing damaged body parts and needs more interdisciplinary research.

Hair loss treatments work better with lifestyle changes.

*Acorus calamus* has many medicinal benefits but needs more safety research.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

CRAC channels are crucial for the development and function of specialized immune cells, preventing severe inflammation and autoimmune diseases.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

Spironolactone is better than placebo for reducing excessive hair growth in women, but its effectiveness for acne is unclear due to small study sizes.

Fibrosing alopecia in a pattern distribution is a hair loss condition often confused with other types, requiring early treatment but usually not resulting in significant hair regrowth.